Humanized Drug Targets
Humanized Drug Targets
|
Cell Line
|
Cancer Type
|
Category
|
Organism
|
Animal Model
|
Strain State
|
|||
|---|---|---|---|---|---|---|---|---|
|
Con
|
Expr
|
TC
|
Parma
|
|||||
| A20-Crbn-V380E/I391V | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-H11-hCD19-Luc | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-H11-hCD19/hCD20-Luc | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-H11-hCD20-Luc | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-hBCMA | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-hCD22 | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-hCD40 | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| A20-hCD47 | Lymphoma | Humanized Drug Targets | Mus musculus | BALB/c |
|
|||
| A20-hCRBN | Lymphoma | Humanized Drug Targets | Mus musculus |
|
||||
| B16F10-H11-hMET | Humanized Drug Targets |
|
||||||
|
|
||||||||
